Neoplasms, Fibroepithelial: Clinical Trials

2 trials for Neoplasms, Fibroepithelial, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2

Follow Neoplasms, Fibroepithelial: new trials by email Literature Review of Neoplasms, Fibroepithelial trials Research Report on Neoplasms, Fibroepithelial

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Behavioral Dietary Intervention, Compliance Monitoring, Counseling - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma
Phase 3UnknownGynecologic Oncology Group10702012-06-182018-02-19
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
Clinical Observation, Laboratory Biomarker Analysis, Paclitaxel - Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma
Phase 3UnknownGOG Foundation11572005-03-212021-09-30

Narrower conditions

Brenner Tumor (2)  ·  Fallopian Tube Neoplasms (2)

Broader conditions

Adnexal Diseases (2)  ·  Endocrine System Diseases (2)  ·  Fallopian Tube Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Gonadal Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)

Interventions

Counseling (1)  ·  Early Intervention, Educational (1)  ·  Educational Status (1)  ·  Methods (1)  ·  Observation (1)  ·  Paclitaxel (1)  ·  Taxes (1)  ·  Watchful Waiting (1)  ·  paclitaxel poliglumex (1)

Sponsors

GOG Foundation (1)  ·  Gynecologic Oncology Group (1)

Countries

United States (2)

Top investigators

David Alberts (1)  ·  Larry J Copeland (1)

Results publications

PMID 27394382, PMID 35759733, PMID 36608382

NIH funding

U10CA027469 (1), U10CA101165 (1), U10CA180830 (1), U10CA180868 (1), UG1CA189867 (1)